Chief Healthcare Executive January 25, 2022
Investors project more deals to be done due to the transformation of healthcare and a host of other factors.
Investors are confident there will be more mergers and acquisitions in healthcare and life sciences in 2022, according to a new report from KPMG.
The 2022 KPMG Healthcare and Life Sciences Investment Outlook surveyed more than 300 industry executives and gauged their opinions on the market.
The survey found 70% of healthcare and life sciences respondents said they plan to increase their merger and acquisition activity in 2022. Four in 10 life sciences investors and 30% of healthcare investors said they plan to increase deal activity by 10% or more in 2022, compared to 2021.
It’s already been a robust market...
Today's Sponsors
Today's Sponsor